Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
REGNRegeneron Pharmaceuticals | $105.45bn | 27.29 | n/a |
VRTXVertex Pharmaceuticals | $103.66bn | 28.87 | n/a |
MRNAModerna | $47.90bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $40.70bn | 28.86 | n/a |
ICLRIcon | $25.55bn | 34.17 | n/a |
BNTXBioNTech SE | $22.04bn | 21.8 | n/a |
ALNYAlnylam Pharmaceuticals | $19.27bn | n/a | n/a |
NBIXNeurocrine Biosciences | $14.16bn | 38.27 | n/a |
SRPTSarepta Therapeutics | $12.63bn | n/a | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
MEDPMedpace Holdings | $12.16bn | 40 | n/a |
TECHBIO-TECHNE | $12.15bn | 53.69 | 0.41% |
CRLCharles River Laboratories International | $12.03bn | 29.48 | n/a |
UTHRUnited Therapeutics | $11.64bn | 12.39 | n/a |
EXASExact Sciences | $11.41bn | n/a | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
QGENQiagen NV | $9.53bn | 25.8 | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |
VKTXViking Therapeutics | $8.49bn | n/a | n/a |